Gates Foundation Governance and Operational Update Epstein Tie Probe and CostCutting Measures Nuveen NEA Stock Analysis Today Risk Aversion 20260420 EMPD Empery posts wider Q3 2023 EPS miss and 755 YoY revenue decline stock falls 172 Recursion Pharmaceuticals RXRX Stock Valuation Perspective Q4 2025 Earnings Beat Estimates AEON AEON Bio posts far wider than projected Q4 2025 loss while shares tick up modestly today